Elevated C4a indicates classical or lectin complement pathway activation.

Complement C4a is a low-molecular-weight peptide, classified as an anaphylatoxin, that serves as a specific biomarker for the activation of the classical and lectin complement pathways. It is released when the parent protein C4 is enzymatically cleaved by C1s or MASP-2 during an immune response.

Clinical and effectiveness evidence

Elevated C4a levels are a validated indicator of active complement turnover across various clinical conditions. Unlike other fragments like C3a or C5a, C4a is uniquely absent during alternative pathway activation, making it a specific diagnostic tool for identifying triggers that engage the classical or lectin pathways.

• Autoimmune conditions: In systemic lupus erythematosus (SLE), C4a levels rise significantly during active flares, correlating with disease severity and the consumption of other complement proteins.
• Biotoxin-related illness: C4a is a primary biomarker used in diagnosing Chronic Inflammatory Response Syndrome (CIRS), where it tracks innate immune dysregulation and neuroinflammation often triggered by mold exposure.
• Infectious triggers: Research identifies C4a as a potential marker in chronic Lyme disease and sepsis, reflecting the system's response to persistent or systemic pathogens.

Mechanistic explanations

The rise of C4a during immune stimulation is driven by specific enzymatic cascades:

• Generation: When the classical pathway is triggered by immune complexes or the lectin pathway by pathogen surfaces, the C4 protein is cleaved. This releases C4a into the plasma as an untethered fragment.
• Downstream effects: Once released, C4a acts as an agonist for protease-activated receptors (PAR1 and PAR4). Although less potent than C5a, it effectively increases endothelial permeability and amplifies inflammatory signaling.
• Specificity: Because C4a is a cleavage product, its presence in serum or plasma provides direct evidence that the early stages of the complement cascade have been successfully triggered by an inflammatory or infectious stimulus.

Bottom line

Elevated C4a is a scientifically validated marker of classical and lectin complement pathway activation that rises in response to autoimmune inflammation, biotoxin exposure, and various infectious challenges.